PRTN3 and rheumatoid arthritis: Potential metabolic differences can serve as indicators of fundamental changes in disease pathogenesis, as enrichment of the OxPhos compared to the glycolysis pathway is evident in the ACPA+ to ACPA− RA comparison and should be investigated further.